参考文献/References:
[1].Ajoolabady A,Pratico D,Lin L,et al. Inflammation in atherosclerosis:pathophysiology and mechanisms[J]. Cell Death Dis,2024,15(11):817.
[2].Yang J,Rong S. The Emerging Role of CircRNAs in Atherosclerosis[J]. Curr Vasc Pharmacol,2023,21(1):26-41.
[3].Miano JM,Fisher EA,Majesky MW. Fate and State of Vascular Smooth Muscle Cells in Atherosclerosis[J]. Circulation,2021,143(21):2110-2116.
[4].Dabravolski SA,Sukhorukov VN,Kalmykov VA,et al.Heat Shock Protein 90 as Therapeutic Target for CVDs and Heart Ageing[J]. Int J Mol Sci,2022,23(2):649.
[5].Grootaert MOJ,Finigan A,Figg NL,et al.SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis[J]. Circ Res,2021,128(4):474-491.
[6].Sarandy MM,Gon?alves RV,Valacchi G. Cutaneous Redox Senescence[J]. Biomedicines,2024,12(2):348.
[7].Zhang L,Pitcher LE,Yousefzadeh MJ,et al. Cellular senescence:a key therapeutic target in aging and diseases[J]. J Clin Invest,2022,132(15):e158450.
[8].Kumari R,Jat P. Mechanisms of Cellular Senescence:Cell Cycle Arrest and Senescence Associated Secretory Phenotype[J]. Front Cell Dev Biol,2021,9:645593.
[9].Guo D,Zhu W,Qiu H. C-C Motif Chemokine Ligand 2 and Chemokine Receptor 2 in Cardiovascular and Neural Aging and Aging-Related Diseases[J]. Int J Mol Sci,2024,25(16):8794.
[10].Lin MJ,Hu SL,Tian Y,et al.Targeting Vascular Smooth Muscle Cell Senescence:A Novel Strategy for Vascular Diseases[J]. J Cardiovasc Transl Res,2023,16(5):1010-1020.
[11].Hernandez-Segura A,Nehme J,Demaria M. Hallmarks of Cellular Senescence[J]. Trends Cell Biol,2018,28(6):436-453.
[12].Sakic A,Chaabane C,Ambartsumian N,et al. Neutralization of S100A4 induces stabilization of atherosclerotic plaques:role of smooth muscle cells[J]. Cardiovasc Res,2022,118(1):141-155.
[13].Ebert S,Zang L,Ismail N,et al.Tissue Inhibitor of Metalloproteinases-1 Interacts with CD74 to Promote AKT Signaling,Monocyte Recruitment Responses,and Vascular Smooth Muscle Cell Proliferation[J]. Cells,2023,12(14):1899.
[14].Olejarz W,?acheta D,Kubiak-Tomaszewska G. Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability[J]. Int J Mol Sci,2020,21(11):3946.
[15].Zhang M,Li L,Zhang W,et al. TG2 participates in pulmonary vascular remodelling by regulating the senescence of pulmonary artery smooth muscle cells[J]. Cell Signal,2024,121:111296.
[16].Guo Y,Tang Z,Yan B,et al. PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Triggers Vascular Smooth Muscle Cell Senescence and Apoptosis:Implication of Its Direct Role in Degenerative Vascular Disease[J]. Arterioscler Thromb Vasc Biol,2022,42(1):67-86.
[17].Lv L,Ye M,Duan R,et al. Downregulation of Pin1 in human atherosclerosis and its association with vascular smooth muscle cell senescence[J]. J Vasc Surg,2018,68(3):873-883.
[18].Kang S,Kang BH. Structure,Function,and Inhibitors of the Mitochondrial Chaperone TRAP1[J]. J Med Chem,2022,65(24):16155-16172.
[19].Joshi A,Ito T,Picard D,et al. The Mitochondrial HSP90 Paralog TRAP1:Structural Dynamics,Interactome,Role in Metabolic Regulation,and Inhibitors[J]. Biomolecules,2022,12(7):880.
[20].Serapian SA,Sanchez-Martín C,Moroni E,et al. Targeting the mitochondrial chaperone TRAP1:strategies and therapeutic perspectives[J]. Trends Pharmacol Sci .2021,42:566-576.
[21].Zhang L,Luo Y,Lv L,et al. TRAP1 inhibits MARCH5-mediated MIC60 degradation to alleviate mitochondrial dysfunction and apoptosis of cardiomyocytes under diabetic conditions[J]. Cell Death Differ,2023,30(10):2336-2350.
[22].Zhang P,Lu Y,Yu D,et al. TRAP1 Provides Protection Against Myocardial Ischemia-Reperfusion Injury by Ameliorating Mitochondrial Dysfunction[J]. Cell Physiol Biochem,2015,36(5):2072-2082.
[23].Cao G,Xuan X,Hu J,et al. How vascular smooth muscle cell phenotype switching contributes to vascular disease[J]. Cell Commun Signal,2022,20(1):180.
[24].Li X,Chen M,Chen X,et al. TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation[J]. Eur Heart J,2024,45(39):4219-4235.
[25].Zhang Y,Huang X,Su T,et al. rtic aneurysm impairs therapeutic efficacy[J]. J Nanobiotechnology,2023,21(1):135.
[26].Maddalena F,Condelli V,Matassa DS,et al.TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas[J]. Mol Oncol,2020,14(12):3030-3047.
[27].Milenkovic D,Misic J,Hevler JF,et al. Preserved respiratory chain capacity and physiology in mice with profoundly reduced levels of mitochondrial respirasomes[J]. Cell Metab,2023,35(10):1799-1813.
[28].Tsai HY,Bronner MP,March JK,et al. Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer[J]. Cancer Lett,2022,549:215915.
[29].Oller J,Gabandé-Rodríguez E,Ruiz-Rodríguez MJ,et al. Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm[J]. Circulation,2021,143(21):2091-2109.
[30].Li X,Yang Y,Zhang B,et al.Lactate metabolism in human health and disease[J]. Signal Transduct Target Ther,2022,7(1):305.
[31].Zhou Y,Chen W,Feng S,et al. Ochratoxin A-induced mitochondrial pathway apoptosis and ferroptosis by promoting glycolysis[J]. Apoptosis,2025,10.1007/s10495-025-02109-w.
[32].Chen AN,Luo Y,Yang YH,et al. Lactylation,a Novel Metabolic Reprogramming Code:Current Status and Prospects[J]. Front Immunol,2021,12:688910.
[33].Wiley CD,Campisi J. The metabolic roots of senescence:mechanisms and opportunities for intervention[J]. Nat Metab,2021,3(10):1290-1301.
[34].Xie S,Xu SC,Deng W,et al. Metabolic landscape in cardiac aging:insights into molecular biology and therapeutic implications[J]. Signal Transduct Target Ther,2023,8(1):114.
[35].Cruz C,Della Rosa M,Krueger C,et al. Tri-methylation of histone H3 lysine 4 facilitates gene expression in ageing cells[J]. Elife,2018,7:e34081.
[36].Pan RY,He L,Zhang J,et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer’s disease[J]. Cell Metab,2022,34(4):634-648.
[37].Moreno-Yruela C,Zhang D,Wei W,et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases[J]. Sci Adv,2022,8(3):eabi6696.
[38].He R,Liu B,Geng B,et al. The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases[J]. Cell Death Discov,2023,9(1):131.
[39].Wang Y,Li H,Jiang S,et al. The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-κB family activation[J]. Kidney Int,2024,106(2):226-240.
[40].Chaib S,Tchkonia T,Kirkland JL. Cellular senescence and senolytics:the path to the clinic[J]. Nat Med,2022,28(8):1556-1568.
[41].Masgras I,Laquatra C,Cannino G,et al. The molecular chaperone TRAP1 in cancer:from the basics of biology to pharmacological targeting[J]. Semin Cancer Biol,2021,76:45-53.
[42].Kim H,Yang J,Kim MJ,et al. Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria[J]. J Biol Chem,2016,291(4):1841-1853.
[43].Guenette RG,Yang SW,Min J,et al. Target and tissue selectivity of PROTAC degraders[J]. Chem Soc Rev,2022,51(14):5740-575
[44].Merfeld T,Peng S,Keegan BM,et al. Elucidation of novel TRAP1-Selective inhibitors that regulate mitochondrial processes[J]. Eur J Med Chem,2023,258:115531.
[45].Reinema FV,Hudson N,Adema GJ,et al. MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells[J]. Radiother Oncol,2024,200:110503.
[46].Yoon NG,Choi D,Lee JH,et al. Development of a Fluorescence Probe for High-Throughput Screening of Allosteric Inhibitors Targeting TRAP1[J]. J Med Chem,2024,67(23):21421-21437.